Thalidomide-NH-(CH2)2-NH-Boc is a functionalized thalidomide derivative optimized for use as an E3 ligase ligand in PROTAC (Proteolysis Targeting Chimera) drug discovery. Featuring an ethylene diamine linker with a Boc (tert-butyloxycarbonyl) protecting group, this compound enables flexible conjugation and compatibility with cereblon (CRBN)-based targeted protein degradation platforms. As a versatile starting material, it facilitates the development of PROTACs and molecular glues for selective protein elimination, supporting advanced research in drug discovery, chemical biology, and therapeutic target validation.
Structure of 1957235-57-2
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
Thalidomide-NH-(CH2)2-NH-Boc is a functionalized thalidomide derivative designed for use as an E3 ligase ligand in targeted protein degradation platforms, such as PROTACs (Proteolysis Targeting Chimeras). The compound incorporates a thalidomide core—the well-characterized CRBN E3 ligase binder—linked via a flexible ethylene diamine (NH-(CH2)2-NH-) spacer to a Boc-protected amine, thereby yielding an ideal handle for further conjugation and PROTAC design.
Mechanism
This molecule operates by binding to the immunomodulatory protein Cereblon (CRBN), the substrate recognition subunit of the CUL4A-CRBN E3 ubiquitin ligase complex. The thalidomide moiety enables high-affinity interaction with CRBN, bringing the E3 ligase in proximity to a target protein when coupled with a suitable ligand. The ethylene diamine linker offers flexibility, and the terminal Boc-protected amine facilitates controlled deprotection and functionalization, allowing efficient coupling of diverse target protein ligands to engineer bifunctional degraders. The recruited ligase catalyzes the polyubiquitination and proteasomal degradation of the tagged target protein.
Applications
Thalidomide-NH-(CH2)2-NH-Boc serves as a foundational building block for the synthesis of CRBN-recruiting PROTACs and related molecular glue degraders. Principal applications include:
• Development of structure-activity relationship (SAR) libraries by enabling modular attachment of varied protein-binding warheads.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.